In this interview we discuss the latest clinical news in urothelial carcinoma, what we’ve learned about the biology of these tumors, and how treatment of this disease has evolved.
In what areas will Secretary Tom Price make an impact at the Department of Health and Human Services? MGMA's government affairs expert shares his insight.
In this interview we discuss a study that found that survivors of thyroid cancer diagnosed with the disease at a young age had an increased risk of late effects from therapy.
One physician nearly died from a ruptured tumor in her liver. From this life threatening experience, she learned the importance of empathy in medicine.
Ahead of the 2017 ASCO Gastrointestinal Cancer Symposium in San Francisco, we spoke with Dr. Geoffrey Ku on the advances in systemic therapy for esophageal and gastric cancer.
In this interview we discuss a recent study that found that more than half of patients with locally advanced cervical cancer in the United States did not receive standard of care.
What are the top healthcare issues that practices will have to pay attention to in the coming year?
In this interview we discuss humanistic medicine and some of the skills that physicians need in order to have open communication with their cancer patients, which can improve the quality of cancer care.
In this interview we discuss the use of liquid biopsies in lung cancer, the pros and cons compared with tissue biopsies, and how they can be used to help make treatment decisions.
In the second of a two-part podcast,. William Maples, MD, explains that improving the patient experience can't happen through hospitality-industry amenities.